Founder Stories: John Maraganore, CEO of Alnylam Pharmaceuticals

John Maraganore is the CEO of Alnylam, the leader in RNAi medicines. Before Alnylam, Maraganore was an SVP at Millennium Pharmaceuticals leading their protein drug development work, and a director at Biogen where he led the work to develop Hirulog, which was ultimately approved for patients with percutaneous transluminal coronary angioplasty (PTCA). https://axialobservations.substack.co... #biotechnology #science #vc #startup #startups #startupideas #biology #biotech #chemistry #business #speech #speeches #investing #investment #lifescience #casestudy #scientist #scientists #inventors #inventor #inventions #invention #research #innovation #siliconvalley #entrepreneur #entrepreneurship #entrepreneurs #healthcare #genomics #genetics #history #biologia #technology #tech #founderstories #founder #founders #founderstory #scienceandtechnology #sciencestory #stories #bioengineering #engineering #engineer #biochemistry #discovery #discover #technical #health #education #educational #learning #learn #podcast #podcasts #podcasting #podcaster #technews Axial Newsletter: https://axial.substack.com/ Build with Axial: https://axial22.axialvc.com/